nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropinirole—CYP1A2—Dacarbazine—pancreatic cancer	0.0464	0.159	CbGbCtD
Ropinirole—CYP1A2—Tamoxifen—pancreatic cancer	0.0369	0.127	CbGbCtD
Ropinirole—CYP1A2—Erlotinib—pancreatic cancer	0.0314	0.108	CbGbCtD
Ropinirole—CYP2D6—Tamoxifen—pancreatic cancer	0.0304	0.104	CbGbCtD
Ropinirole—CYP1A2—Fluorouracil—pancreatic cancer	0.0272	0.0933	CbGbCtD
Ropinirole—CYP2D6—Erlotinib—pancreatic cancer	0.0258	0.0887	CbGbCtD
Ropinirole—CYP3A4—Tamoxifen—pancreatic cancer	0.0193	0.0664	CbGbCtD
Ropinirole—CYP3A4—Erlotinib—pancreatic cancer	0.0164	0.0564	CbGbCtD
Ropinirole—CYP3A4—Irinotecan—pancreatic cancer	0.0148	0.051	CbGbCtD
Ropinirole—CYP2D6—Doxorubicin—pancreatic cancer	0.0127	0.0438	CbGbCtD
Ropinirole—CYP3A4—Docetaxel—pancreatic cancer	0.0109	0.0373	CbGbCtD
Ropinirole—CYP3A4—Sunitinib—pancreatic cancer	0.0108	0.0372	CbGbCtD
Ropinirole—CYP3A4—Doxorubicin—pancreatic cancer	0.00811	0.0278	CbGbCtD
Ropinirole—Haematuria—Epirubicin—pancreatic cancer	0.00012	0.000248	CcSEcCtD
Ropinirole—Confusional state—Docetaxel—pancreatic cancer	0.00012	0.000248	CcSEcCtD
Ropinirole—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000119	0.000247	CcSEcCtD
Ropinirole—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000119	0.000246	CcSEcCtD
Ropinirole—Oedema—Docetaxel—pancreatic cancer	0.000119	0.000246	CcSEcCtD
Ropinirole—Weight increased—Doxorubicin—pancreatic cancer	0.000119	0.000246	CcSEcCtD
Ropinirole—Epistaxis—Epirubicin—pancreatic cancer	0.000119	0.000246	CcSEcCtD
Ropinirole—Pruritus—Gemcitabine—pancreatic cancer	0.000119	0.000246	CcSEcCtD
Ropinirole—Infection—Docetaxel—pancreatic cancer	0.000118	0.000245	CcSEcCtD
Ropinirole—Weight decreased—Doxorubicin—pancreatic cancer	0.000118	0.000245	CcSEcCtD
Ropinirole—Sinusitis—Epirubicin—pancreatic cancer	0.000118	0.000244	CcSEcCtD
Ropinirole—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000118	0.000244	CcSEcCtD
Ropinirole—Diarrhoea—Irinotecan—pancreatic cancer	0.000118	0.000244	CcSEcCtD
Ropinirole—Agranulocytosis—Epirubicin—pancreatic cancer	0.000117	0.000243	CcSEcCtD
Ropinirole—Pneumonia—Doxorubicin—pancreatic cancer	0.000117	0.000242	CcSEcCtD
Ropinirole—Shock—Docetaxel—pancreatic cancer	0.000117	0.000242	CcSEcCtD
Ropinirole—Nervous system disorder—Docetaxel—pancreatic cancer	0.000117	0.000242	CcSEcCtD
Ropinirole—Pruritus—Fluorouracil—pancreatic cancer	0.000117	0.000241	CcSEcCtD
Ropinirole—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000117	0.000241	CcSEcCtD
Ropinirole—Infestation NOS—Doxorubicin—pancreatic cancer	0.000116	0.000241	CcSEcCtD
Ropinirole—Infestation—Doxorubicin—pancreatic cancer	0.000116	0.000241	CcSEcCtD
Ropinirole—Tachycardia—Docetaxel—pancreatic cancer	0.000116	0.00024	CcSEcCtD
Ropinirole—Skin disorder—Docetaxel—pancreatic cancer	0.000116	0.000239	CcSEcCtD
Ropinirole—Bradycardia—Epirubicin—pancreatic cancer	0.000115	0.000238	CcSEcCtD
Ropinirole—Diarrhoea—Gemcitabine—pancreatic cancer	0.000115	0.000237	CcSEcCtD
Ropinirole—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000114	0.000236	CcSEcCtD
Ropinirole—Dizziness—Irinotecan—pancreatic cancer	0.000114	0.000236	CcSEcCtD
Ropinirole—Haemoglobin—Epirubicin—pancreatic cancer	0.000114	0.000235	CcSEcCtD
Ropinirole—Stomatitis—Doxorubicin—pancreatic cancer	0.000114	0.000235	CcSEcCtD
Ropinirole—Anorexia—Docetaxel—pancreatic cancer	0.000113	0.000235	CcSEcCtD
Ropinirole—Rhinitis—Epirubicin—pancreatic cancer	0.000113	0.000234	CcSEcCtD
Ropinirole—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000113	0.000234	CcSEcCtD
Ropinirole—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000113	0.000234	CcSEcCtD
Ropinirole—Haemorrhage—Epirubicin—pancreatic cancer	0.000113	0.000234	CcSEcCtD
Ropinirole—Diarrhoea—Fluorouracil—pancreatic cancer	0.000113	0.000233	CcSEcCtD
Ropinirole—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000112	0.000233	CcSEcCtD
Ropinirole—Pharyngitis—Epirubicin—pancreatic cancer	0.000112	0.000232	CcSEcCtD
Ropinirole—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000112	0.000231	CcSEcCtD
Ropinirole—Oedema peripheral—Epirubicin—pancreatic cancer	0.000111	0.00023	CcSEcCtD
Ropinirole—Hypotension—Docetaxel—pancreatic cancer	0.000111	0.00023	CcSEcCtD
Ropinirole—Haematuria—Doxorubicin—pancreatic cancer	0.000111	0.00023	CcSEcCtD
Ropinirole—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000111	0.00023	CcSEcCtD
Ropinirole—Urethral disorder—Epirubicin—pancreatic cancer	0.000111	0.000229	CcSEcCtD
Ropinirole—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.00011	0.000228	CcSEcCtD
Ropinirole—Epistaxis—Doxorubicin—pancreatic cancer	0.00011	0.000227	CcSEcCtD
Ropinirole—Vomiting—Irinotecan—pancreatic cancer	0.000109	0.000227	CcSEcCtD
Ropinirole—Sinusitis—Doxorubicin—pancreatic cancer	0.000109	0.000226	CcSEcCtD
Ropinirole—Dizziness—Fluorouracil—pancreatic cancer	0.000109	0.000226	CcSEcCtD
Ropinirole—Visual impairment—Epirubicin—pancreatic cancer	0.000109	0.000225	CcSEcCtD
Ropinirole—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000109	0.000225	CcSEcCtD
Ropinirole—Rash—Irinotecan—pancreatic cancer	0.000109	0.000225	CcSEcCtD
Ropinirole—Dermatitis—Irinotecan—pancreatic cancer	0.000108	0.000224	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000108	0.000224	CcSEcCtD
Ropinirole—Headache—Irinotecan—pancreatic cancer	0.000108	0.000223	CcSEcCtD
Ropinirole—Insomnia—Docetaxel—pancreatic cancer	0.000108	0.000223	CcSEcCtD
Ropinirole—Paraesthesia—Docetaxel—pancreatic cancer	0.000107	0.000221	CcSEcCtD
Ropinirole—Vomiting—Gemcitabine—pancreatic cancer	0.000107	0.000221	CcSEcCtD
Ropinirole—Bradycardia—Doxorubicin—pancreatic cancer	0.000106	0.00022	CcSEcCtD
Ropinirole—Dyspnoea—Docetaxel—pancreatic cancer	0.000106	0.00022	CcSEcCtD
Ropinirole—Somnolence—Docetaxel—pancreatic cancer	0.000106	0.000219	CcSEcCtD
Ropinirole—Rash—Gemcitabine—pancreatic cancer	0.000106	0.000219	CcSEcCtD
Ropinirole—Dermatitis—Gemcitabine—pancreatic cancer	0.000106	0.000219	CcSEcCtD
Ropinirole—Eye disorder—Epirubicin—pancreatic cancer	0.000106	0.000218	CcSEcCtD
Ropinirole—Tinnitus—Epirubicin—pancreatic cancer	0.000105	0.000218	CcSEcCtD
Ropinirole—Haemoglobin—Doxorubicin—pancreatic cancer	0.000105	0.000217	CcSEcCtD
Ropinirole—Headache—Gemcitabine—pancreatic cancer	0.000105	0.000217	CcSEcCtD
Ropinirole—Flushing—Epirubicin—pancreatic cancer	0.000105	0.000217	CcSEcCtD
Ropinirole—Cardiac disorder—Epirubicin—pancreatic cancer	0.000105	0.000217	CcSEcCtD
Ropinirole—Vomiting—Fluorouracil—pancreatic cancer	0.000105	0.000217	CcSEcCtD
Ropinirole—Rhinitis—Doxorubicin—pancreatic cancer	0.000105	0.000217	CcSEcCtD
Ropinirole—Dyspepsia—Docetaxel—pancreatic cancer	0.000105	0.000217	CcSEcCtD
Ropinirole—Haemorrhage—Doxorubicin—pancreatic cancer	0.000105	0.000216	CcSEcCtD
Ropinirole—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000104	0.000215	CcSEcCtD
Ropinirole—Rash—Fluorouracil—pancreatic cancer	0.000104	0.000215	CcSEcCtD
Ropinirole—Dermatitis—Fluorouracil—pancreatic cancer	0.000104	0.000215	CcSEcCtD
Ropinirole—Pharyngitis—Doxorubicin—pancreatic cancer	0.000104	0.000215	CcSEcCtD
Ropinirole—Decreased appetite—Docetaxel—pancreatic cancer	0.000103	0.000214	CcSEcCtD
Ropinirole—Headache—Fluorouracil—pancreatic cancer	0.000103	0.000214	CcSEcCtD
Ropinirole—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000103	0.000214	CcSEcCtD
Ropinirole—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000103	0.000213	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000103	0.000213	CcSEcCtD
Ropinirole—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000103	0.000213	CcSEcCtD
Ropinirole—Fatigue—Docetaxel—pancreatic cancer	0.000103	0.000212	CcSEcCtD
Ropinirole—Angiopathy—Epirubicin—pancreatic cancer	0.000103	0.000212	CcSEcCtD
Ropinirole—Urethral disorder—Doxorubicin—pancreatic cancer	0.000103	0.000212	CcSEcCtD
Ropinirole—Nausea—Irinotecan—pancreatic cancer	0.000102	0.000212	CcSEcCtD
Ropinirole—Immune system disorder—Epirubicin—pancreatic cancer	0.000102	0.000211	CcSEcCtD
Ropinirole—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000102	0.000211	CcSEcCtD
Ropinirole—Constipation—Docetaxel—pancreatic cancer	0.000102	0.000211	CcSEcCtD
Ropinirole—Pain—Docetaxel—pancreatic cancer	0.000102	0.000211	CcSEcCtD
Ropinirole—Chills—Epirubicin—pancreatic cancer	0.000101	0.00021	CcSEcCtD
Ropinirole—Arrhythmia—Epirubicin—pancreatic cancer	0.000101	0.000209	CcSEcCtD
Ropinirole—Visual impairment—Doxorubicin—pancreatic cancer	0.000101	0.000208	CcSEcCtD
Ropinirole—Alopecia—Epirubicin—pancreatic cancer	9.99e-05	0.000207	CcSEcCtD
Ropinirole—Nausea—Gemcitabine—pancreatic cancer	9.96e-05	0.000206	CcSEcCtD
Ropinirole—Mental disorder—Epirubicin—pancreatic cancer	9.9e-05	0.000205	CcSEcCtD
Ropinirole—Malnutrition—Epirubicin—pancreatic cancer	9.84e-05	0.000204	CcSEcCtD
Ropinirole—Feeling abnormal—Docetaxel—pancreatic cancer	9.81e-05	0.000203	CcSEcCtD
Ropinirole—Nausea—Fluorouracil—pancreatic cancer	9.8e-05	0.000203	CcSEcCtD
Ropinirole—Eye disorder—Doxorubicin—pancreatic cancer	9.77e-05	0.000202	CcSEcCtD
Ropinirole—Tinnitus—Doxorubicin—pancreatic cancer	9.75e-05	0.000202	CcSEcCtD
Ropinirole—Gastrointestinal pain—Docetaxel—pancreatic cancer	9.73e-05	0.000201	CcSEcCtD
Ropinirole—Flushing—Doxorubicin—pancreatic cancer	9.71e-05	0.000201	CcSEcCtD
Ropinirole—Cardiac disorder—Doxorubicin—pancreatic cancer	9.71e-05	0.000201	CcSEcCtD
Ropinirole—Flatulence—Epirubicin—pancreatic cancer	9.7e-05	0.000201	CcSEcCtD
Ropinirole—Tension—Epirubicin—pancreatic cancer	9.65e-05	0.0002	CcSEcCtD
Ropinirole—Dysgeusia—Epirubicin—pancreatic cancer	9.63e-05	0.000199	CcSEcCtD
Ropinirole—Nervousness—Epirubicin—pancreatic cancer	9.56e-05	0.000198	CcSEcCtD
Ropinirole—Back pain—Epirubicin—pancreatic cancer	9.52e-05	0.000197	CcSEcCtD
Ropinirole—Angiopathy—Doxorubicin—pancreatic cancer	9.49e-05	0.000196	CcSEcCtD
Ropinirole—Muscle spasms—Epirubicin—pancreatic cancer	9.46e-05	0.000196	CcSEcCtD
Ropinirole—Immune system disorder—Doxorubicin—pancreatic cancer	9.45e-05	0.000195	CcSEcCtD
Ropinirole—Mediastinal disorder—Doxorubicin—pancreatic cancer	9.42e-05	0.000195	CcSEcCtD
Ropinirole—Abdominal pain—Docetaxel—pancreatic cancer	9.41e-05	0.000195	CcSEcCtD
Ropinirole—Body temperature increased—Docetaxel—pancreatic cancer	9.41e-05	0.000195	CcSEcCtD
Ropinirole—Chills—Doxorubicin—pancreatic cancer	9.38e-05	0.000194	CcSEcCtD
Ropinirole—Arrhythmia—Doxorubicin—pancreatic cancer	9.34e-05	0.000193	CcSEcCtD
Ropinirole—Vision blurred—Epirubicin—pancreatic cancer	9.27e-05	0.000192	CcSEcCtD
Ropinirole—Alopecia—Doxorubicin—pancreatic cancer	9.24e-05	0.000191	CcSEcCtD
Ropinirole—Mental disorder—Doxorubicin—pancreatic cancer	9.16e-05	0.00019	CcSEcCtD
Ropinirole—Ill-defined disorder—Epirubicin—pancreatic cancer	9.13e-05	0.000189	CcSEcCtD
Ropinirole—Malnutrition—Doxorubicin—pancreatic cancer	9.1e-05	0.000188	CcSEcCtD
Ropinirole—Anaemia—Epirubicin—pancreatic cancer	9.09e-05	0.000188	CcSEcCtD
Ropinirole—Agitation—Epirubicin—pancreatic cancer	9.04e-05	0.000187	CcSEcCtD
Ropinirole—Flatulence—Doxorubicin—pancreatic cancer	8.97e-05	0.000186	CcSEcCtD
Ropinirole—Tension—Doxorubicin—pancreatic cancer	8.93e-05	0.000185	CcSEcCtD
Ropinirole—Dysgeusia—Doxorubicin—pancreatic cancer	8.91e-05	0.000184	CcSEcCtD
Ropinirole—Malaise—Epirubicin—pancreatic cancer	8.87e-05	0.000184	CcSEcCtD
Ropinirole—Nervousness—Doxorubicin—pancreatic cancer	8.84e-05	0.000183	CcSEcCtD
Ropinirole—Vertigo—Epirubicin—pancreatic cancer	8.84e-05	0.000183	CcSEcCtD
Ropinirole—Syncope—Epirubicin—pancreatic cancer	8.82e-05	0.000183	CcSEcCtD
Ropinirole—Leukopenia—Epirubicin—pancreatic cancer	8.81e-05	0.000182	CcSEcCtD
Ropinirole—Back pain—Doxorubicin—pancreatic cancer	8.81e-05	0.000182	CcSEcCtD
Ropinirole—Hypersensitivity—Docetaxel—pancreatic cancer	8.77e-05	0.000181	CcSEcCtD
Ropinirole—Muscle spasms—Doxorubicin—pancreatic cancer	8.75e-05	0.000181	CcSEcCtD
Ropinirole—Palpitations—Epirubicin—pancreatic cancer	8.69e-05	0.00018	CcSEcCtD
Ropinirole—Loss of consciousness—Epirubicin—pancreatic cancer	8.65e-05	0.000179	CcSEcCtD
Ropinirole—Cough—Epirubicin—pancreatic cancer	8.59e-05	0.000178	CcSEcCtD
Ropinirole—Vision blurred—Doxorubicin—pancreatic cancer	8.58e-05	0.000177	CcSEcCtD
Ropinirole—Asthenia—Docetaxel—pancreatic cancer	8.54e-05	0.000177	CcSEcCtD
Ropinirole—Convulsion—Epirubicin—pancreatic cancer	8.52e-05	0.000176	CcSEcCtD
Ropinirole—Hypertension—Epirubicin—pancreatic cancer	8.49e-05	0.000176	CcSEcCtD
Ropinirole—Ill-defined disorder—Doxorubicin—pancreatic cancer	8.45e-05	0.000175	CcSEcCtD
Ropinirole—Pruritus—Docetaxel—pancreatic cancer	8.42e-05	0.000174	CcSEcCtD
Ropinirole—Anaemia—Doxorubicin—pancreatic cancer	8.41e-05	0.000174	CcSEcCtD
Ropinirole—Chest pain—Epirubicin—pancreatic cancer	8.38e-05	0.000173	CcSEcCtD
Ropinirole—Arthralgia—Epirubicin—pancreatic cancer	8.38e-05	0.000173	CcSEcCtD
Ropinirole—Myalgia—Epirubicin—pancreatic cancer	8.38e-05	0.000173	CcSEcCtD
Ropinirole—Agitation—Doxorubicin—pancreatic cancer	8.37e-05	0.000173	CcSEcCtD
Ropinirole—Anxiety—Epirubicin—pancreatic cancer	8.35e-05	0.000173	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	8.32e-05	0.000172	CcSEcCtD
Ropinirole—Discomfort—Epirubicin—pancreatic cancer	8.28e-05	0.000171	CcSEcCtD
Ropinirole—Malaise—Doxorubicin—pancreatic cancer	8.21e-05	0.00017	CcSEcCtD
Ropinirole—Dry mouth—Epirubicin—pancreatic cancer	8.19e-05	0.000169	CcSEcCtD
Ropinirole—Vertigo—Doxorubicin—pancreatic cancer	8.18e-05	0.000169	CcSEcCtD
Ropinirole—Syncope—Doxorubicin—pancreatic cancer	8.16e-05	0.000169	CcSEcCtD
Ropinirole—Leukopenia—Doxorubicin—pancreatic cancer	8.15e-05	0.000169	CcSEcCtD
Ropinirole—Diarrhoea—Docetaxel—pancreatic cancer	8.15e-05	0.000168	CcSEcCtD
Ropinirole—Confusional state—Epirubicin—pancreatic cancer	8.1e-05	0.000167	CcSEcCtD
Ropinirole—Palpitations—Doxorubicin—pancreatic cancer	8.04e-05	0.000166	CcSEcCtD
Ropinirole—Oedema—Epirubicin—pancreatic cancer	8.03e-05	0.000166	CcSEcCtD
Ropinirole—Loss of consciousness—Doxorubicin—pancreatic cancer	8e-05	0.000166	CcSEcCtD
Ropinirole—Infection—Epirubicin—pancreatic cancer	7.98e-05	0.000165	CcSEcCtD
Ropinirole—Cough—Doxorubicin—pancreatic cancer	7.94e-05	0.000164	CcSEcCtD
Ropinirole—Shock—Epirubicin—pancreatic cancer	7.9e-05	0.000163	CcSEcCtD
Ropinirole—Convulsion—Doxorubicin—pancreatic cancer	7.89e-05	0.000163	CcSEcCtD
Ropinirole—Nervous system disorder—Epirubicin—pancreatic cancer	7.87e-05	0.000163	CcSEcCtD
Ropinirole—Dizziness—Docetaxel—pancreatic cancer	7.87e-05	0.000163	CcSEcCtD
Ropinirole—Thrombocytopenia—Epirubicin—pancreatic cancer	7.86e-05	0.000163	CcSEcCtD
Ropinirole—Hypertension—Doxorubicin—pancreatic cancer	7.86e-05	0.000163	CcSEcCtD
Ropinirole—Tachycardia—Epirubicin—pancreatic cancer	7.84e-05	0.000162	CcSEcCtD
Ropinirole—Skin disorder—Epirubicin—pancreatic cancer	7.8e-05	0.000161	CcSEcCtD
Ropinirole—Hyperhidrosis—Epirubicin—pancreatic cancer	7.76e-05	0.000161	CcSEcCtD
Ropinirole—Myalgia—Doxorubicin—pancreatic cancer	7.75e-05	0.00016	CcSEcCtD
Ropinirole—Arthralgia—Doxorubicin—pancreatic cancer	7.75e-05	0.00016	CcSEcCtD
Ropinirole—Chest pain—Doxorubicin—pancreatic cancer	7.75e-05	0.00016	CcSEcCtD
Ropinirole—Anxiety—Doxorubicin—pancreatic cancer	7.72e-05	0.00016	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	7.7e-05	0.000159	CcSEcCtD
Ropinirole—Discomfort—Doxorubicin—pancreatic cancer	7.66e-05	0.000158	CcSEcCtD
Ropinirole—Anorexia—Epirubicin—pancreatic cancer	7.65e-05	0.000158	CcSEcCtD
Ropinirole—Dry mouth—Doxorubicin—pancreatic cancer	7.58e-05	0.000157	CcSEcCtD
Ropinirole—Vomiting—Docetaxel—pancreatic cancer	7.57e-05	0.000157	CcSEcCtD
Ropinirole—Rash—Docetaxel—pancreatic cancer	7.51e-05	0.000155	CcSEcCtD
Ropinirole—Hypotension—Epirubicin—pancreatic cancer	7.5e-05	0.000155	CcSEcCtD
Ropinirole—Dermatitis—Docetaxel—pancreatic cancer	7.5e-05	0.000155	CcSEcCtD
Ropinirole—Confusional state—Doxorubicin—pancreatic cancer	7.49e-05	0.000155	CcSEcCtD
Ropinirole—Headache—Docetaxel—pancreatic cancer	7.46e-05	0.000154	CcSEcCtD
Ropinirole—Oedema—Doxorubicin—pancreatic cancer	7.43e-05	0.000154	CcSEcCtD
Ropinirole—Infection—Doxorubicin—pancreatic cancer	7.38e-05	0.000153	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	7.32e-05	0.000151	CcSEcCtD
Ropinirole—Shock—Doxorubicin—pancreatic cancer	7.31e-05	0.000151	CcSEcCtD
Ropinirole—Nervous system disorder—Doxorubicin—pancreatic cancer	7.29e-05	0.000151	CcSEcCtD
Ropinirole—Thrombocytopenia—Doxorubicin—pancreatic cancer	7.27e-05	0.00015	CcSEcCtD
Ropinirole—Insomnia—Epirubicin—pancreatic cancer	7.26e-05	0.00015	CcSEcCtD
Ropinirole—Tachycardia—Doxorubicin—pancreatic cancer	7.25e-05	0.00015	CcSEcCtD
Ropinirole—Skin disorder—Doxorubicin—pancreatic cancer	7.22e-05	0.000149	CcSEcCtD
Ropinirole—Paraesthesia—Epirubicin—pancreatic cancer	7.21e-05	0.000149	CcSEcCtD
Ropinirole—Hyperhidrosis—Doxorubicin—pancreatic cancer	7.18e-05	0.000149	CcSEcCtD
Ropinirole—Dyspnoea—Epirubicin—pancreatic cancer	7.16e-05	0.000148	CcSEcCtD
Ropinirole—Somnolence—Epirubicin—pancreatic cancer	7.14e-05	0.000148	CcSEcCtD
Ropinirole—Anorexia—Doxorubicin—pancreatic cancer	7.08e-05	0.000147	CcSEcCtD
Ropinirole—Nausea—Docetaxel—pancreatic cancer	7.07e-05	0.000146	CcSEcCtD
Ropinirole—Dyspepsia—Epirubicin—pancreatic cancer	7.07e-05	0.000146	CcSEcCtD
Ropinirole—Decreased appetite—Epirubicin—pancreatic cancer	6.98e-05	0.000144	CcSEcCtD
Ropinirole—Hypotension—Doxorubicin—pancreatic cancer	6.94e-05	0.000144	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Epirubicin—pancreatic cancer	6.93e-05	0.000143	CcSEcCtD
Ropinirole—Fatigue—Epirubicin—pancreatic cancer	6.92e-05	0.000143	CcSEcCtD
Ropinirole—Constipation—Epirubicin—pancreatic cancer	6.87e-05	0.000142	CcSEcCtD
Ropinirole—Pain—Epirubicin—pancreatic cancer	6.87e-05	0.000142	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	6.77e-05	0.00014	CcSEcCtD
Ropinirole—Insomnia—Doxorubicin—pancreatic cancer	6.72e-05	0.000139	CcSEcCtD
Ropinirole—Paraesthesia—Doxorubicin—pancreatic cancer	6.67e-05	0.000138	CcSEcCtD
Ropinirole—Dyspnoea—Doxorubicin—pancreatic cancer	6.62e-05	0.000137	CcSEcCtD
Ropinirole—Feeling abnormal—Epirubicin—pancreatic cancer	6.62e-05	0.000137	CcSEcCtD
Ropinirole—Somnolence—Doxorubicin—pancreatic cancer	6.61e-05	0.000137	CcSEcCtD
Ropinirole—Gastrointestinal pain—Epirubicin—pancreatic cancer	6.57e-05	0.000136	CcSEcCtD
Ropinirole—Dyspepsia—Doxorubicin—pancreatic cancer	6.54e-05	0.000135	CcSEcCtD
Ropinirole—Decreased appetite—Doxorubicin—pancreatic cancer	6.46e-05	0.000134	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	6.41e-05	0.000133	CcSEcCtD
Ropinirole—Fatigue—Doxorubicin—pancreatic cancer	6.41e-05	0.000133	CcSEcCtD
Ropinirole—Urticaria—Epirubicin—pancreatic cancer	6.38e-05	0.000132	CcSEcCtD
Ropinirole—Constipation—Doxorubicin—pancreatic cancer	6.35e-05	0.000131	CcSEcCtD
Ropinirole—Pain—Doxorubicin—pancreatic cancer	6.35e-05	0.000131	CcSEcCtD
Ropinirole—Body temperature increased—Epirubicin—pancreatic cancer	6.35e-05	0.000131	CcSEcCtD
Ropinirole—Abdominal pain—Epirubicin—pancreatic cancer	6.35e-05	0.000131	CcSEcCtD
Ropinirole—Feeling abnormal—Doxorubicin—pancreatic cancer	6.12e-05	0.000127	CcSEcCtD
Ropinirole—Gastrointestinal pain—Doxorubicin—pancreatic cancer	6.08e-05	0.000126	CcSEcCtD
Ropinirole—Hypersensitivity—Epirubicin—pancreatic cancer	5.92e-05	0.000122	CcSEcCtD
Ropinirole—Urticaria—Doxorubicin—pancreatic cancer	5.9e-05	0.000122	CcSEcCtD
Ropinirole—Abdominal pain—Doxorubicin—pancreatic cancer	5.87e-05	0.000121	CcSEcCtD
Ropinirole—Body temperature increased—Doxorubicin—pancreatic cancer	5.87e-05	0.000121	CcSEcCtD
Ropinirole—Asthenia—Epirubicin—pancreatic cancer	5.76e-05	0.000119	CcSEcCtD
Ropinirole—Pruritus—Epirubicin—pancreatic cancer	5.68e-05	0.000118	CcSEcCtD
Ropinirole—Diarrhoea—Epirubicin—pancreatic cancer	5.49e-05	0.000114	CcSEcCtD
Ropinirole—Hypersensitivity—Doxorubicin—pancreatic cancer	5.47e-05	0.000113	CcSEcCtD
Ropinirole—Asthenia—Doxorubicin—pancreatic cancer	5.33e-05	0.00011	CcSEcCtD
Ropinirole—Dizziness—Epirubicin—pancreatic cancer	5.31e-05	0.00011	CcSEcCtD
Ropinirole—Pruritus—Doxorubicin—pancreatic cancer	5.26e-05	0.000109	CcSEcCtD
Ropinirole—Vomiting—Epirubicin—pancreatic cancer	5.11e-05	0.000106	CcSEcCtD
Ropinirole—Diarrhoea—Doxorubicin—pancreatic cancer	5.08e-05	0.000105	CcSEcCtD
Ropinirole—Rash—Epirubicin—pancreatic cancer	5.06e-05	0.000105	CcSEcCtD
Ropinirole—Dermatitis—Epirubicin—pancreatic cancer	5.06e-05	0.000105	CcSEcCtD
Ropinirole—Headache—Epirubicin—pancreatic cancer	5.03e-05	0.000104	CcSEcCtD
Ropinirole—Dizziness—Doxorubicin—pancreatic cancer	4.91e-05	0.000102	CcSEcCtD
Ropinirole—Nausea—Epirubicin—pancreatic cancer	4.77e-05	9.87e-05	CcSEcCtD
Ropinirole—Vomiting—Doxorubicin—pancreatic cancer	4.72e-05	9.77e-05	CcSEcCtD
Ropinirole—Rash—Doxorubicin—pancreatic cancer	4.68e-05	9.69e-05	CcSEcCtD
Ropinirole—Dermatitis—Doxorubicin—pancreatic cancer	4.68e-05	9.68e-05	CcSEcCtD
Ropinirole—Headache—Doxorubicin—pancreatic cancer	4.65e-05	9.63e-05	CcSEcCtD
Ropinirole—Nausea—Doxorubicin—pancreatic cancer	4.41e-05	9.13e-05	CcSEcCtD
Ropinirole—HTR2C—Signaling Pathways—CXCL8—pancreatic cancer	1.03e-05	4.58e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—HRAS—pancreatic cancer	1.03e-05	4.57e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—STAT3—pancreatic cancer	1.03e-05	4.56e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CASP3—pancreatic cancer	1.03e-05	4.56e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—NRAS—pancreatic cancer	1.03e-05	4.55e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—HRAS—pancreatic cancer	1.03e-05	4.55e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—MYC—pancreatic cancer	1.02e-05	4.51e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—EGFR—pancreatic cancer	1.02e-05	4.51e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—TGFB1—pancreatic cancer	1.02e-05	4.5e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PIK3CB—pancreatic cancer	1.01e-05	4.5e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—EGFR—pancreatic cancer	1.01e-05	4.48e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—SRC—pancreatic cancer	1.01e-05	4.46e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PTGS2—pancreatic cancer	1.01e-05	4.46e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CXCL8—pancreatic cancer	1e-05	4.45e-05	CbGpPWpGaD
Ropinirole—HTR1A—GPCR downstream signaling—AKT1—pancreatic cancer	1e-05	4.45e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—MYC—pancreatic cancer	1e-05	4.44e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CCND1—pancreatic cancer	1e-05	4.44e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—TGFB1—pancreatic cancer	9.99e-06	4.43e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—HRAS—pancreatic cancer	9.97e-06	4.42e-05	CbGpPWpGaD
Ropinirole—HTR2C—GPCR downstream signaling—AKT1—pancreatic cancer	9.97e-06	4.42e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—TYMS—pancreatic cancer	9.96e-06	4.42e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—EGFR—pancreatic cancer	9.95e-06	4.42e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CASP3—pancreatic cancer	9.93e-06	4.4e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—SRC—pancreatic cancer	9.93e-06	4.4e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CTNNB1—pancreatic cancer	9.91e-06	4.4e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CD44—pancreatic cancer	9.91e-06	4.4e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CASP3—pancreatic cancer	9.88e-06	4.38e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—VEGFA—pancreatic cancer	9.8e-06	4.35e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—EGFR—pancreatic cancer	9.79e-06	4.35e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—PIK3CA—pancreatic cancer	9.78e-06	4.34e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PIK3CD—pancreatic cancer	9.73e-06	4.32e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MMP9—pancreatic cancer	9.72e-06	4.31e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—STAT3—pancreatic cancer	9.7e-06	4.3e-05	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—AKT1—pancreatic cancer	9.7e-06	4.3e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—NRAS—pancreatic cancer	9.68e-06	4.29e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—VEGFA—pancreatic cancer	9.67e-06	4.29e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CCND1—pancreatic cancer	9.66e-06	4.29e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—PTEN—pancreatic cancer	9.66e-06	4.29e-05	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	9.64e-06	4.28e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—PIK3CA—pancreatic cancer	9.62e-06	4.27e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CCND1—pancreatic cancer	9.61e-06	4.27e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CASP3—pancreatic cancer	9.61e-06	4.26e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—KRAS—pancreatic cancer	9.6e-06	4.26e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—STAT3—pancreatic cancer	9.57e-06	4.25e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CTNNB1—pancreatic cancer	9.57e-06	4.25e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—APOE—pancreatic cancer	9.56e-06	4.24e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—MYC—pancreatic cancer	9.56e-06	4.24e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—NRAS—pancreatic cancer	9.55e-06	4.24e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—TGFB1—pancreatic cancer	9.54e-06	4.23e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—KRAS—pancreatic cancer	9.53e-06	4.23e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CTNNB1—pancreatic cancer	9.52e-06	4.22e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—GCG—pancreatic cancer	9.5e-06	4.22e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PIK3CB—pancreatic cancer	9.48e-06	4.2e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—AKT1—pancreatic cancer	9.43e-06	4.18e-05	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—AKT1—pancreatic cancer	9.41e-06	4.17e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—KRAS—pancreatic cancer	9.4e-06	4.17e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MMP9—pancreatic cancer	9.38e-06	4.16e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CCND1—pancreatic cancer	9.35e-06	4.15e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—EGFR—pancreatic cancer	9.35e-06	4.15e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MMP9—pancreatic cancer	9.33e-06	4.14e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—PTEN—pancreatic cancer	9.33e-06	4.14e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PIK3CB—pancreatic cancer	9.33e-06	4.14e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—PTEN—pancreatic cancer	9.28e-06	4.12e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CTNNB1—pancreatic cancer	9.26e-06	4.11e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—KRAS—pancreatic cancer	9.25e-06	4.1e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CXCL8—pancreatic cancer	9.11e-06	4.04e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—AKT1—pancreatic cancer	9.1e-06	4.04e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MMP9—pancreatic cancer	9.08e-06	4.03e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—AKT1—pancreatic cancer	9.05e-06	4.02e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—HRAS—pancreatic cancer	9.05e-06	4.01e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—PTEN—pancreatic cancer	9.03e-06	4e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MYC—pancreatic cancer	9.01e-06	4e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—TGFB1—pancreatic cancer	8.99e-06	3.99e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CXCL8—pancreatic cancer	8.96e-06	3.98e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—SRC—pancreatic cancer	8.96e-06	3.98e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—STK11—pancreatic cancer	8.94e-06	3.96e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—HRAS—pancreatic cancer	8.9e-06	3.95e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MYC—pancreatic cancer	8.89e-06	3.95e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—TGFB1—pancreatic cancer	8.87e-06	3.94e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—KRAS—pancreatic cancer	8.83e-06	3.92e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—PIK3CA—pancreatic cancer	8.82e-06	3.91e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—EGFR—pancreatic cancer	8.82e-06	3.91e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—AKT1—pancreatic cancer	8.81e-06	3.91e-05	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—AKT1—pancreatic cancer	8.8e-06	3.9e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PTEN—pancreatic cancer	8.77e-06	3.89e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—PIK3CA—pancreatic cancer	8.76e-06	3.88e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—VEGFA—pancreatic cancer	8.73e-06	3.87e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CASP3—pancreatic cancer	8.72e-06	3.87e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—EGFR—pancreatic cancer	8.7e-06	3.86e-05	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—AKT1—pancreatic cancer	8.66e-06	3.84e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—SRC—pancreatic cancer	8.65e-06	3.84e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—STAT3—pancreatic cancer	8.64e-06	3.83e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—PIK3CA—pancreatic cancer	8.64e-06	3.83e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	8.63e-06	3.83e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—NRAS—pancreatic cancer	8.62e-06	3.82e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—SRC—pancreatic cancer	8.61e-06	3.82e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CASP3—pancreatic cancer	8.58e-06	3.81e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—TP53—pancreatic cancer	8.53e-06	3.79e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—PIK3CA—pancreatic cancer	8.5e-06	3.77e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CCND1—pancreatic cancer	8.49e-06	3.76e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PIK3CB—pancreatic cancer	8.48e-06	3.76e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—VEGFA—pancreatic cancer	8.43e-06	3.74e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CTNNB1—pancreatic cancer	8.4e-06	3.73e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—VEGFA—pancreatic cancer	8.38e-06	3.72e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—SRC—pancreatic cancer	8.37e-06	3.71e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—TP53—pancreatic cancer	8.36e-06	3.71e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CCND1—pancreatic cancer	8.35e-06	3.7e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—STAT3—pancreatic cancer	8.34e-06	3.7e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—KRAS—pancreatic cancer	8.33e-06	3.7e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PPARG—pancreatic cancer	8.33e-06	3.69e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—NRAS—pancreatic cancer	8.32e-06	3.69e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—STAT3—pancreatic cancer	8.3e-06	3.68e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—NRAS—pancreatic cancer	8.28e-06	3.67e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CTNNB1—pancreatic cancer	8.27e-06	3.67e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MMP9—pancreatic cancer	8.24e-06	3.65e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—TP53—pancreatic cancer	8.22e-06	3.65e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—KRAS—pancreatic cancer	8.22e-06	3.65e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PTEN—pancreatic cancer	8.19e-06	3.63e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—HRAS—pancreatic cancer	8.16e-06	3.62e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CXCL8—pancreatic cancer	8.15e-06	3.62e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—VEGFA—pancreatic cancer	8.15e-06	3.62e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—PIK3CA—pancreatic cancer	8.11e-06	3.6e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MMP9—pancreatic cancer	8.11e-06	3.6e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—HRAS—pancreatic cancer	8.1e-06	3.59e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—APOE—pancreatic cancer	8.1e-06	3.59e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—STAT3—pancreatic cancer	8.07e-06	3.58e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PTEN—pancreatic cancer	8.06e-06	3.57e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—NRAS—pancreatic cancer	8.05e-06	3.57e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MYC—pancreatic cancer	8.03e-06	3.56e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—TGFB1—pancreatic cancer	8.01e-06	3.55e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—HRAS—pancreatic cancer	7.99e-06	3.55e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	7.99e-06	3.54e-05	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—AKT1—pancreatic cancer	7.88e-06	3.49e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—HRAS—pancreatic cancer	7.86e-06	3.49e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—AKT1—pancreatic cancer	7.86e-06	3.49e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—EGFR—pancreatic cancer	7.85e-06	3.48e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—TP53—pancreatic cancer	7.85e-06	3.48e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CASP3—pancreatic cancer	7.8e-06	3.46e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MYC—pancreatic cancer	7.75e-06	3.44e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—TGFB1—pancreatic cancer	7.73e-06	3.43e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MYC—pancreatic cancer	7.71e-06	3.42e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—TGFB1—pancreatic cancer	7.69e-06	3.41e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—TYMS—pancreatic cancer	7.69e-06	3.41e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	7.67e-06	3.4e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—PIK3CA—pancreatic cancer	7.65e-06	3.39e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—PIK3CA—pancreatic cancer	7.62e-06	3.38e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CCND1—pancreatic cancer	7.6e-06	3.37e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—SRC—pancreatic cancer	7.6e-06	3.37e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	7.59e-06	3.37e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—EGFR—pancreatic cancer	7.58e-06	3.36e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—PIK3CA—pancreatic cancer	7.55e-06	3.35e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—EGFR—pancreatic cancer	7.54e-06	3.35e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CTNNB1—pancreatic cancer	7.52e-06	3.34e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—HRAS—pancreatic cancer	7.51e-06	3.33e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MYC—pancreatic cancer	7.5e-06	3.33e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—TGFB1—pancreatic cancer	7.48e-06	3.32e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—SRC—pancreatic cancer	7.47e-06	3.32e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—KRAS—pancreatic cancer	7.42e-06	3.29e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—TP53—pancreatic cancer	7.4e-06	3.28e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	7.4e-06	3.28e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MMP9—pancreatic cancer	7.37e-06	3.27e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—EGFR—pancreatic cancer	7.34e-06	3.25e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PTEN—pancreatic cancer	7.33e-06	3.25e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—STAT3—pancreatic cancer	7.32e-06	3.25e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	7.31e-06	3.24e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—NRAS—pancreatic cancer	7.31e-06	3.24e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—TP53—pancreatic cancer	7.3e-06	3.24e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—VEGFA—pancreatic cancer	7.28e-06	3.23e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—AKT1—pancreatic cancer	7.21e-06	3.2e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—STAT3—pancreatic cancer	7.21e-06	3.2e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—NRAS—pancreatic cancer	7.19e-06	3.19e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—KRAS—pancreatic cancer	7.16e-06	3.18e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—AKT1—pancreatic cancer	7.15e-06	3.17e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—KRAS—pancreatic cancer	7.13e-06	3.16e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—HRAS—pancreatic cancer	7.08e-06	3.14e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—AKT1—pancreatic cancer	7.06e-06	3.13e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PPARG—pancreatic cancer	7.06e-06	3.13e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—HRAS—pancreatic cancer	6.99e-06	3.1e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—AKT1—pancreatic cancer	6.94e-06	3.08e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—KRAS—pancreatic cancer	6.93e-06	3.07e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—PIK3CA—pancreatic cancer	6.82e-06	3.02e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MYC—pancreatic cancer	6.81e-06	3.02e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—SRC—pancreatic cancer	6.8e-06	3.02e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	6.79e-06	3.01e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MYC—pancreatic cancer	6.7e-06	2.97e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TGFB1—pancreatic cancer	6.68e-06	2.96e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—EGFR—pancreatic cancer	6.66e-06	2.95e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—AKT1—pancreatic cancer	6.63e-06	2.94e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—VEGFA—pancreatic cancer	6.62e-06	2.94e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	6.61e-06	2.93e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—TP53—pancreatic cancer	6.59e-06	2.93e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—PIK3CA—pancreatic cancer	6.58e-06	2.92e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—STAT3—pancreatic cancer	6.56e-06	2.91e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PTGS2—pancreatic cancer	6.55e-06	2.91e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—EGFR—pancreatic cancer	6.55e-06	2.91e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—PIK3CA—pancreatic cancer	6.55e-06	2.9e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—NRAS—pancreatic cancer	6.54e-06	2.9e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	6.43e-06	2.85e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—PIK3CA—pancreatic cancer	6.37e-06	2.82e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—TP53—pancreatic cancer	6.37e-06	2.82e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—TP53—pancreatic cancer	6.33e-06	2.81e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—HRAS—pancreatic cancer	6.31e-06	2.8e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—KRAS—pancreatic cancer	6.29e-06	2.79e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—AKT1—pancreatic cancer	6.25e-06	2.77e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—APOE—pancreatic cancer	6.25e-06	2.77e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—AKT1—pancreatic cancer	6.22e-06	2.76e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—KRAS—pancreatic cancer	6.19e-06	2.75e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—PIK3CA—pancreatic cancer	6.19e-06	2.74e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—AKT1—pancreatic cancer	6.17e-06	2.74e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—TP53—pancreatic cancer	6.16e-06	2.73e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MYC—pancreatic cancer	6.09e-06	2.7e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—HRAS—pancreatic cancer	6.09e-06	2.7e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TGFB1—pancreatic cancer	6.08e-06	2.7e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—HRAS—pancreatic cancer	6.06e-06	2.69e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—EGFR—pancreatic cancer	5.96e-06	2.64e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—HRAS—pancreatic cancer	5.89e-06	2.61e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	5.78e-06	2.56e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PTEN—pancreatic cancer	5.71e-06	2.53e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—PIK3CA—pancreatic cancer	5.69e-06	2.52e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	5.64e-06	2.5e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—KRAS—pancreatic cancer	5.63e-06	2.5e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	5.6e-06	2.48e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TP53—pancreatic cancer	5.59e-06	2.48e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—AKT1—pancreatic cancer	5.57e-06	2.47e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PTGS2—pancreatic cancer	5.55e-06	2.46e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TP53—pancreatic cancer	5.5e-06	2.44e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PPARG—pancreatic cancer	5.45e-06	2.42e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—AKT1—pancreatic cancer	5.38e-06	2.38e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—AKT1—pancreatic cancer	5.35e-06	2.37e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—HRAS—pancreatic cancer	5.35e-06	2.37e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—HRAS—pancreatic cancer	5.26e-06	2.33e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—AKT1—pancreatic cancer	5.2e-06	2.31e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—PIK3CA—pancreatic cancer	5.17e-06	2.29e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—AKT1—pancreatic cancer	5.05e-06	2.24e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TP53—pancreatic cancer	5e-06	2.22e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	4.96e-06	2.2e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PTEN—pancreatic cancer	4.84e-06	2.15e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—HRAS—pancreatic cancer	4.79e-06	2.12e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—AKT1—pancreatic cancer	4.72e-06	2.09e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—AKT1—pancreatic cancer	4.64e-06	2.06e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	4.32e-06	1.92e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PTGS2—pancreatic cancer	4.28e-06	1.9e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—AKT1—pancreatic cancer	4.23e-06	1.87e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	4.03e-06	1.79e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PTEN—pancreatic cancer	3.74e-06	1.66e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	3.41e-06	1.51e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—AKT1—pancreatic cancer	3.29e-06	1.46e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—AKT1—pancreatic cancer	2.79e-06	1.24e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.64e-06	1.17e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—AKT1—pancreatic cancer	2.15e-06	9.55e-06	CbGpPWpGaD
